What does it mean to have an EGFR mutation for cancer patients?
What does it mean to have an EGFR mutation for cancer patients?
An EGFR mutation refers to a mutation (damage) to the portion of the DNA in a lung cancer cell which carries the “recipe” for making EGFR (epidermal growth factor receptor) proteins.
What is EGFR mutation test?
An EGFR mutation test may be ordered by itself or as part of a panel (a series of tests to detect mutations in other genes such as KRAS, ALK and ROS1). Each of these tests may be used to help determine whether a person’s lung cancer will respond to targeted therapy and which type will be of more benefit.
What causes the EGFR mutation?
The most common EGFR mutations include missing genetic material on exon 19 (19-del) or damage to exon 21 (21-L858R). These two mutations account for about 85% of the EGFR mutations of lung cancer cells. Exon 20 insertion mutations may also occur, but they are much rarer.
What type of cancer is EGFR?
EGFR (epidermal growth factor receptor, also known as ERBB1 and HER1) is a gene that encodes for the epidermal growth factor receptor protein. Missense mutations, deletions, and insertions are observed in cancers such as lung cancer and glioblastoma.
Is the EGFR gene activating in metaplastic breast carcinomas?
In this study, EGFR gene amplification as defined by chromogenic in situ hybridization and protein overexpression was examined in a cohort of 47 metaplastic breast carcinomas. Furthermore, the presence of activating EGFR mutations in exons 18, 19, 20, and 21 was investigated.
Can you test for EGFR positive breast cancer?
While EGFR amplification testing is not regularly done, some doctors are starting to request it on breast cancer tissue samples. Possible results are “EGFR-positive,” “EGFR-negative,” or “undetermined.” Other EGFR-positive cancers, such as colon cancer, respond to medicines that target EGFR-positive cancers.
What is the status of the EGFR gene?
Some genes and the proteins they make can influence how a breast cancer behaves and how it might respond to a specific treatment. In addition to results for HER2 gene testing, your pathology report may include information about the status of the EGFR (Epidermal Growth Factor Receptor) gene, sometimes known as the HER1 gene.